Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 16/20 | 0.52 |
| ▸ | CTSV | O60911 | 2/20 | 0.52 |
| ▸ | CTSL | P07711 | 2/20 | 0.52 |
| ▸ | CNR1 | P21554 | 5/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | GUCY1A1 | Q02108 | 1/20 | 0.42 |
| ▸ | GUCY1B1 | Q02153 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6152142 | 0.86 | CTSV (0.49) | CTSVCTSLGPR84 | |
| SCHEMBL6153219 | 0.83 | CTSV (0.52) | CTSVCTSLGPR84 | |
| SCHEMBL6152297 | 0.81 | MEN1 (0.47) | CNR2CTSVCTSLCNR1 | |
| SCHEMBL6151728 | 0.81 | RARB (0.54) | CTSVCTSLGPR84 | |
| SCHEMBL6152182 | 0.78 | MPL (0.52) | CTSVCTSLGPR84 | |
| SCHEMBL6153025 | 0.75 | RARB (0.47) | CTSVCTSLGPR84 | |
| SCHEMBL6152138 | 0.74 | TSHR (0.55) | CTSVCTSLGPR84 | |
| SCHEMBL10513486 | 0.70 | CTSV (0.68) | CTSVCTSLGPR84CYP2C9 | |
| SCHEMBL8998711 | 0.70 | CTSV (0.68) | CTSVCTSLGPR84CYP2C9 | |
| Naphthoic Acid SCHEMBL31550365 | 0.69 | CNR2 (0.49) | CNR2CNR1CYP2C9GUCY1A1GUCY1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1253151-B1 | Pyrromethene metal complex and light emitting device composition and light emitting devices using the same | TORAY INDUSTRIES (JP) | 2005-01-12 | — | — | EP | disclosed |
| US-6805978-B2 | COMPLEX CONTAINING DIKETOPYRROLO(3,4-C)PYRROLE COMPOUND | TORAY INDUSTRIES, INC. (JP) | 2004-10-19 | — | — | US | disclosed |
| US-20030082406-A1 | Complex containing diketopyrrolo(3,4-c)pyrrole compound | TORAY INDUSTRIES, INC. (JP) | 2003-05-01 | — | — | US | disclosed |
| EP-1253151-A1 | Pyrromethene metal complex and light emitting device composition and light emitting devices using the same | TORAY INDUSTRIES, INC. (JP) | 2002-10-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030082406-A1 | Complex containing diketopyrrolo(3,4-c)pyrrole compound | PPOX, CPNE4, TP53RK | CNR2 1724/4885CTSV 2058/4885CTSL 2295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.